Rapid Pathogen Detection
PCR technology supports faster identification of infectious disease pathogens than many conventional methods.
Technology
Advanced Polymerase Chain Reaction technology supports rapid pathogen detection, antibiotic resistance marker identification, and actionable diagnostic information.
PCR Technology
Ipsum Diagnostics utilizes Polymerase Chain Reaction technology to detect infectious disease pathogens and antibiotic resistance markers with exceptional sensitivity and specificity.
PCR technology supports faster identification of infectious disease pathogens than many conventional methods.
Molecular methods help identify organisms that may be difficult to detect through traditional approaches.
Detection of resistance genes helps clinicians consider therapy options and stewardship needs.
Clinically meaningful diagnostic information supports earlier intervention and improved patient care.
Why Molecular Testing
Molecular diagnostic information can help providers act sooner with greater clinical confidence.
Molecular diagnostic information can help providers act sooner with greater clinical confidence.
Molecular diagnostic information can help providers act sooner with greater clinical confidence.
Molecular diagnostic information can help providers act sooner with greater clinical confidence.
Molecular diagnostic information can help providers act sooner with greater clinical confidence.
Molecular diagnostic information can help providers act sooner with greater clinical confidence.
Laboratory Information
Ipsum Diagnostics utilizes advanced Polymerase Chain Reaction (PCR) technology to detect infectious disease pathogens and antibiotic resistance markers with exceptional sensitivity and specificity.
PCR technology enables the laboratory to identify organisms that may be difficult or impossible to detect through traditional methodologies, providing clinicians with actionable diagnostic information faster than conventional testing methods.
Molecular testing benefits include rapid pathogen detection, enhanced diagnostic accuracy, earlier treatment intervention, identification of antibiotic resistance genes, improved patient outcomes, and support for antimicrobial stewardship initiatives.
Partner with Ipsum Diagnostics